Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/73656
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLokman, N.en
dc.contributor.authorElder, A.en
dc.contributor.authorRicciardelli, C.en
dc.contributor.authorOehler, M.en
dc.date.issued2012en
dc.identifier.citationInternational Journal of Molecular Sciences, 2012; 13(8):9959-9970en
dc.identifier.issn1661-6596en
dc.identifier.issn1422-0067en
dc.identifier.urihttp://hdl.handle.net/2440/73656-
dc.description.abstractThe majority of ovarian cancer patients present with advanced disease and despite aggressive treatment, prognosis remains poor. Significant improvement in ovarian cancer survival will require the development of more effective molecularly targeted therapeutics. Commonly, mouse models are used for the in vivo assessment of potential new therapeutic targets in ovarian cancer. However, animal models are costly and time consuming. Other models, such as the chick embryo chorioallantoic membrane (CAM) assay, are therefore an attractive alternative. CAM assays have been widely used to study angiogenesis and tumor invasion of colorectal, prostate and brain cancers. However, there have been limited studies that have used CAM assays to assess ovarian cancer invasion and metastasis. We have therefore developed a CAM assay protocol to monitor the metastatic properties of ovarian cancer cells (OVCAR-3, SKOV-3 and OV-90) and to study the effect of potential therapeutic molecules in vivo. The results from the CAM assay are consistent with cancer cell motility and invasion observed in in vitro assays. Our results demonstrate that the CAM assay is a robust and cost effective model to study ovarian cancer cell metastasis. It is therefore a very useful in vivo model for screening of potential novel therapeutics.en
dc.description.statementofresponsibilityNoor A. Lokman, Alison S.F. Elder, Carmela Ricciardelli and Martin K. Oehleren
dc.language.isoenen
dc.publisherMDPI AGen
dc.rights© 2012 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).en
dc.subjectOvarian cancer; invasion; metastasis; chick chorioallantoic membraneen
dc.titleChick chorioallantoic membrane (CAM) assay as an in vivo model to study the effect of newly identified molecules on ovarian cancer invasion and metastasisen
dc.typeJournal articleen
dc.identifier.rmid0020121515en
dc.identifier.doi10.3390/ijms13089959en
dc.identifier.pubid23408-
pubs.library.collectionObstetrics and Gynaecology publicationsen
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
dc.identifier.orcidRicciardelli, C. [0000-0001-7415-1854]en
Appears in Collections:Obstetrics and Gynaecology publications

Files in This Item:
File Description SizeFormat 
hdl_73656.pdfPublished version228.42 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.